Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT01343043 |
| Title | A Pilot Study of Genetically Engineered NY-ESO-1 Specific NY-ESO-1c259T in HLA-A2+ Patients With Synovial Sarcoma (NY-ESO-1) |
| Acronym | NY-ESO-1 |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Adaptimmune |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult | child |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| GSK Investigational Site | Duarte | California | 91010 | United States | Details | |
| GSK Investigational Site | Miami | Florida | 33136 | United States | Details | |
| GSK Investigational Site | Tampa | Florida | 33612 | United States | Details | |
| GSK Investigational Site | Bethesda | Maryland | 20892 | United States | Details | |
| GSK Investigational Site | Boston | Massachusetts | 02114 | United States | Details | |
| GSK Investigational Site | Saint Louis | Missouri | 63110 | United States | Details | |
| GSK Investigational Site | New York | New York | 10065 | United States | Details | |
| GSK Investigational Site | Houston | Texas | 77030 | United States | Details |